Fig. 2From: Health care cost associated with the use of enzyme-inducing and non-enzyme–active antiepileptic drugs in the UK: a long-term retrospective matched cohort studyStandardized monthly all-cause direct health care cost in each post-index year for the matched cohorts. Whiskers extend from the 10th to the 90th percentile; boxes extend from the 25th to the 75th percentile; center line is the median; red cross is the mean. EIAED enzyme-inducing antiepileptic drug, nEAAED non-enzyme–active antiepileptic drugBack to article page